NasdaqGS - Nasdaq Real Time Price USD

Tempus AI, Inc (TEM)

Compare
63.02 -8.45 (-11.82%)
As of 1:41 PM EDT. Market Open.
Loading Chart for TEM
DELL
  • Previous Close 71.47
  • Open 72.50
  • Bid 54.87 x 200
  • Ask 63.56 x 100
  • Day's Range 61.05 - 77.00
  • 52 Week Range 22.89 - 77.00
  • Volume 1,782,206
  • Avg. Volume 1,340,600
  • Market Cap (intraday) 9.725B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -11.55
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 45.86

Tempus AI, Inc operates as a healthcare technology company. It engages in providing next generation sequencing diagnostics, polymerase chain reaction profiling, molecular genotyping, and other anatomic and molecular pathology testing to healthcare providers, pharmaceutical companies, biotechnology companies, researchers, and other third parties. The company also offers Insights, a license library of linked clinical, molecular, and imaging de-identified data, as well as a suite of analytical services to analytic and cloud-and-compute tools to pharmaceutical and biotechnology companies; and Trials that provides clinical trial matching services to pharmaceutical companies. In addition, it operates Next; Algos, a suite of algorithmic tests in oncology; Hub, a desktop and mobile platform for ordering, managing, and receiving tests and patient results; and Lens, a platform for researchers and scientists to find, access, and analyze Tempus data. The company has a collaboration with united therapeutics to study use of AI to detect patients at risk for pulmonary hypertension. The company was formerly known as Tempus Labs, Inc. and changed its name to Tempus AI, Inc in January 2023. Tempus AI, Inc was incorporated in 2015 and is headquartered in Chicago, Illinois.

www.tempus.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: TEM

View More

Research Reports: TEM

View More

Performance Overview: TEM

Trailing total returns as of 8/22/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

TEM
57.55%
S&P 500
2.71%

1-Year Return

TEM
57.55%
S&P 500
2.71%

3-Year Return

TEM
57.55%
S&P 500
2.71%

5-Year Return

TEM
57.55%
S&P 500
2.71%

Compare To: TEM

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: TEM

View More

Valuation Measures

Annual
As of 8/21/2024
  • Market Cap

    11.03B

  • Enterprise Value

    11.01B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    19.77

  • Price/Book (mrq)

    112.25

  • Enterprise Value/Revenue

    18.49

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -121.04%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    595.57M

  • Net Income Avi to Common (ttm)

    -790.2M

  • Diluted EPS (ttm)

    -11.55

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    490.07M

  • Total Debt/Equity (mrq)

    484.03%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: TEM

View More

Company Insights: TEM

People Also Watch